AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Digene Corp. (DIGE) announced that by the spring of this year, its DNAwithPap Test will be offered to all women 30 and older by Kaiser Permanente's Northern California Region, to better identify who is at risk of developing cervical cancer.
Although other healthcare plans and insurers have begun paying for the test when ordered by physicians, Kaiser will be the first to implement it as a "standard of care" for routine cervical cancer screening, along with the traditional Pap smear. The Northern California region is the largest of the Kaiser Permanente systems, with nearly 3.2 million members.
The DNAwithPap Test - the only such test approved by the U.S. Food and Drug Administration - detects the presence of high-risk types of human papillomavirus (HPV), which have been shown to cause virtually all cases of cervical cancer. The plan to be adopted by Kaiser Permanente throughout Northern California calls for women 30 and older to be offered the HPV test along with a Pap smear during their regular check-ups, with follow-up testing as needed depending on the results.
"It is not a surprise that Kaiser Permanente is the first healthcare organization to adopt HPV testing as a standard of care in routine cervical cancer screening, since it has been a leader in cervical cancer screening," said Evan Jones, Digene's chairman and CEO, noting that more than 80% of Kaiser's female patients receive regular Pap smears, compared to the national average of 69%. "The FDA approval of our DNAwithPap Test was earned in part due to research conducted by the organization. Kaiser Permanente also played a key role in the research performed ...
Source: HighBeam Research, California organization says it will be first to use HPV test...